PDLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PDL BioPharma Inc's other long-term assets for the quarter that ended in Sep. 2014 was $395.9 Mil.
PDL BioPharma Inc's quarterly other long-term assets increased from Mar. 2014 ($273.2 Mil) to Jun. 2014 ($439.2 Mil) but then declined from Jun. 2014 ($439.2 Mil) to Sep. 2014 ($395.9 Mil).
PDL BioPharma Inc's annual other long-term assets increased from Dec. 2011 ($35.9 Mil) to Dec. 2012 ($96.9 Mil) and increased from Dec. 2012 ($96.9 Mil) to Dec. 2013 ($200.5 Mil).
Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.
A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
PDL BioPharma Inc Annual Data
|Other Long-Term Assets||44.2||62.7||110.2||50.2||9.3||22.4||31.9||35.9||96.9||200.5|
PDL BioPharma Inc Quarterly Data
|Other Long-Term Assets||23.0||47.0||96.9||54.0||117.4||96.7||200.5||273.2||439.2||395.9|